Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02367092 · ClinicalTrials.gov registry record · NA
Exercise Intervention in Liver Transplant Patients
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT02367092 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 83 participants.
The verdict
NCT02367092, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about the effects of exercise on functional status and outcomes on patients with end-stage liver disease on the liver transplant waiting list and who have undergone liver transplantation.
Interventions
- BEHAVIORAL Exercise Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2016-07 |
| Est. Completion | 2019-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02367092
The ClinicalTrials.gov registry entry for NCT02367092 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exercise Program is the first listed.
NCT02367092 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02367092 about?
NCT02367092 is a clinical study titled "Exercise Intervention in Liver Transplant Patients". The purpose of this study is to learn more about the effects of exercise on functional status and outcomes on patients with end-stage liver disease on the liver transplant waiting list and who have undergone liver transplantation.
What is the current status of trial NCT02367092?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2016-07. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02367092?
The interventions under investigation include: Exercise Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02367092?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.